Joseph Steven Kluck is a pharmacist who is specialized in Pharmacotherapy in Philadelphia, Pennsylvania. Patients can reach him at 3900 Woodland Ave, Pharmacy Services, Philadelphia or contact him on 215-823-5800. Active license number of Joseph Steven Kluck is RP4444046 for Pharmacotherapy in Pennsylvania. Joseph Steven Kluck is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Joseph Steven Kluck speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Joseph Steven Kluck are as mentioned below.
NPI Number:
1841509957
NPI Enumeration Date:
07 Oct, 2010
NPI Last Update On:
07 Oct, 2010
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Joseph Steven Kluck are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
RP4444046
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
121 W Allen St, Philadelphia, Pennsylvania
Zip:
19123-1616
Phone Number:
--
Fax Number:
--
Patients can reach Joseph Steven Kluck at 3900 Woodland Ave, Pharmacy Services, Philadelphia, Pennsylvania or can call on phone at 215-823-5800.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.